Overview Fundamentals API Earnings EOD API Sample Code Pricing

Gilead Sciences Inc (GILD NASDAQ) stock market data APIs

$76.03 -0.98(-1.3%) as of July 26, 2024
Price chart is built with Anychart

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Gilead Sciences Inc Financial Data Overview

77.01
76.03
-
78.29
75.7515
61.3181-85.9254
95 320 M
212.5278
1 246 M
27 450 M
-1.32
0.0402
0.2
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'GILD',
Type: 'Common Stock',
Name: 'Gilead Sciences Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000CKGBP2',
ISIN: NULL,
CUSIP: NULL,
CIK: '882095',
EmployerIdNumber: '94-3047598',
FiscalYearEnd: 'December',
IPODate: '1992-01-22',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Gilead Sciences Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 27 450 M
  • EBITDA 12 665 M
  • Earnings Per Share 0.36
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Gilead Sciences Inc Earnings via APIs

  • Latest Release 2024-04-25
  • EPS/Forecast -1.49

Get Gilead Sciences Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com